UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024473
Receipt number R000028156
Scientific Title A retrospective multicenter study of carbon ion radiotherapy for the head and neck cancer except sarcoma: Japan Carbon Ion Radiotherapy Study Group Study (1402 HN)
Date of disclosure of the study information 2016/10/19
Last modified on 2016/10/18 20:52:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective multicenter study of carbon ion radiotherapy for the head and neck cancer except sarcoma: Japan Carbon Ion Radiotherapy Study Group Study (1402 HN)

Acronym

J-CROS 1402 HN

Scientific Title

A retrospective multicenter study of carbon ion radiotherapy for the head and neck cancer except sarcoma: Japan Carbon Ion Radiotherapy Study Group Study (1402 HN)

Scientific Title:Acronym

J-CROS 1402 HN

Region

Japan


Condition

Condition

Head and neck cancer except sarcoma

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of carbon ion radiotherapy for patients with head and neck cancer except sarcoma treated with carbon ion radiotherapy in Japan.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Overall survival rate
Local control rate
Adverse event

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) histologically confirmed malignancy (except choroidal melanoma), no bone or soft tissue tumors, 2) N0 or N1 M0 status, 3) medically inoperable tumors or surgery refusal, 4) definitive intent, 5) measurable tumors, and 6) an Eastern Cooperative Oncology Group performance status of 0-2.

Key exclusion criteria

Patients who previously underwent irradiation for the same lesion were excluded.

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tadashi Kamada

Organization

National Institutes for Quantum and
Radiological Sciences and Technology

Division name

National Institute of Radiological Science Hospital

Zip code


Address

Anagawa 4-9-1, Inage-ku 263-8555 Chiba

TEL

043-206-3360

Email

kamada.tadashi@qst.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masashi Koto

Organization

National Institutes for Quantum and Radiological Sciences and Technology

Division name

National Institute of Radiological Science Hospital

Zip code


Address

Anagawa 4-9-1, Inage-ku 263-8555 Chiba

TEL

043-206-3360

Homepage URL


Email

koto.masashi@qst.go.jp


Sponsor or person

Institute

National Institutes for Quantum and Radiological Sciences and Technology

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 10 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 03 Month 31 Day

Date of IRB


Anticipated trial start date

2015 Year 04 Month 27 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2016 Year 10 Month 18 Day

Last modified on

2016 Year 10 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028156


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name